Advertisement
Organisation › Details
Promore Pharma (Group)
Promore Pharma is a biopharmaceutical company specialized in the development of therapeutic peptides for the bioactive wound care market. The company’s aim is to develop two first-in-category products for indications where very few efficacious prescription pharmaceuticals are available, thus, addressing high unmet medical needs. Promore Pharma has two projects, PXL01 and LL-37, in late stage clinical phase. PXL01, that will be used for prevention of post-surgical adhesions and scars, is being prepared for clinical phase III-studies on patients undergoing tendon repair surgery in the hand and LL-37 that is prepared for a clinical phase IIb study on patients with venous leg ulcers. The product candidates can also be deployed for other indications, such as preventing dermal scarring and treatment of diabetic foot ulcers. Rosetta Capital Ltd., Midroc New Technology AB and PharmaResearch Products Ltd. are the main shareholders in Promore Pharma. *
Start | 2016-07-01 renamed | |
Predecessor | Pergamum AB | |
Industry | pharmaceutical | |
Person | Ekblom, Jonas (Pergamum AB 201302 CEO) | |
Region | Solna | |
Country | Sweden | |
Street | 2 Fogdevreten Karolinska Institutet Science Park (KISP) | |
City | 17165 Solna | |
Tel | +46-8-1245-4859 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
Currency | SEK | |
Cash | 3,800,000 (2017-03-31) | |
* Document for »About Section«: Promore Pharma AB. (5/19/17). "Press Release: Interim Report January - March 2017". | ||
Record changed: 2024-02-12 |
Advertisement
More documents for Promore Pharma (Group)
- [1] Promore Pharma AB. (5/19/17). "Press Release: Interim Report January - March 2017"....
- [2] Promore Pharma AB. (5/17/17). "Press Release: Promore Pharma AB Files Phase III Clinical Trial Application in India". Stockholm....
- [3] Promore Pharma AB. (4/26/17). "Press Release: Promore Pharma AB Elects Marianne Dicander Alexandersson as New Board Member and Outlines Plans for IPO". Stockholm....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top